Invention Grant
- Patent Title: G proteins
-
Application No.: US15549246Application Date: 2017-01-27
-
Publication No.: US10738287B2Publication Date: 2020-08-11
- Inventor: Byron Carpenter , Andrew Leslie , Rony Nehmé , Christopher Gordon Tate , Antony Warne
- Applicant: HEPTARES THERAPEUTICS LIMITED
- Applicant Address: GB Welwyn Garden City, Hertfordshire
- Assignee: Heptares Therapeutics Limited
- Current Assignee: Heptares Therapeutics Limited
- Current Assignee Address: GB Welwyn Garden City, Hertfordshire
- Agency: Mueting, Raasch & Gebhardt, P.A.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@120f5c10
- International Application: PCT/GB2017/050221 WO 20170127
- International Announcement: WO2017/129998 WO 20170803
- Main IPC: C12N9/14
- IPC: C12N9/14 ; C07K14/47 ; G01N33/566 ; C07K14/72 ; C07K14/705

Abstract:
The invention provides a mutant of a parent heterotrimeric G protein alpha (Gα) subunit, which mutant (i) lacks at least one helix of the helical domain of the parent Gα subunit; (ii) is capable of binding to a GPCR in the absence of a heterotrimeric G protein beta (Gβ) subunit and a heterotrimeric G protein gamma (Gγ) subunit; and (iii) has an amino acid sequence that contains one or more mutations compared to the amino acid sequence of the parent heterotrimeric Gα subunit, which mutations are selected from a deletion, a substitution and an insertion.
Public/Granted literature
- US20190032033A1 G PROTEINS Public/Granted day:2019-01-31
Information query